Blog
Health Canada Compliance Insights
NHPD testing guides, Canadian regulatory updates, and compliance insights for natural health product manufacturers, supplement brands, and Amazon Canada sellers.
Selecting a Contract Research Organization in Canada: What Pharma Sponsors Actually Need to Evaluate
Not all Canadian CROs are equal. Learn five criteria pharma sponsors must check before outsourcing to a contract research organization in Canada.
Dissolution Testing for Canadian Generic Drug Submissions: What Health Canada Reviewers Actually Check
What Health Canada reviewers look for in ANDS dissolution packages — f2 criteria, BCS biowaivers, and the data deficiencies that delay DIN approval.
Post-Market Pharmacovigilance in Canada: What Your CRO or CMO Is Actually Responsible For
Health Canada pharmacovigilance obligations for Canadian CROs and CMOs: 15-day ADR reporting, PSUR requirements, and what Vanessa's Law changed.
ANDS in Canada: Bioequivalence Requirements, the Canadian Reference Product Rule, and Common Submission Pitfalls
Planning an Abbreviated New Drug Submission in Canada? Learn Health Canada's bioequivalence requirements, the Canadian Reference Product rule, and the most common ANDS pitfalls.
Orphan Drug Designation in Canada: What Rare Disease Sponsors Need to Know Before Filing with Health Canada
Canada has no Orphan Drug Act — but rare disease sponsors have real pathways. Learn how Priority Review, NOC/c, and Project Orbis work under Health Canada.
Why Your NPN Application Gets Rejected — And How to Fix It Before Submission
Health Canada NPN applications fail for predictable reasons. Learn the five most common rejection causes and what to fix before you file your NHPD submission.
Impurity Profiling in API Development: What Health Canada's ICH Q3A Requirements Actually Demand
How Health Canada applies ICH Q3A and Q3D impurity guidelines in practice — thresholds, genotoxic limits, and what a defensible Canadian NDS package requires.
NPN Application Requirements: Why Health Canada Issues a Notice of Deficiency (And How to Avoid It)
Learn why NPN applications receive a Notice of Deficiency from Health Canada and how to address evidence, labelling, quality, and site licence gaps before you submit.
Product Licence Amendments: When and How to Update Your NPN with Health Canada
A practical guide to Health Canada's NPN product licence amendment requirements: when to file, what to include, and how to plan around 210-day timelines.
Why Your NPN Application Gets Rejected: Common Deficiencies in Health Canada Submissions
Health Canada returns more NPN applications than most manufacturers expect. Learn the most common deficiencies—and how to avoid them before you submit.
How to Choose a Contract Research Organization in Canada: What Health Canada Submissions Really Demand
Selecting a contract research organization in Canada requires more than comparing prices. Here's what Health Canada's GMP framework actually demands from your CRO.
NHPD Site Licence Requirements: What Canadian Manufacturers and Importers Really Need to Know
Health Canada's NHPD Site Licence requirements explained — who needs one, what GMP evidence to prepare, and how to structure your application for first-pass approval.
Filing a Clinical Trial Application in Canada: A Practical Guide for Sponsors and CROs
A step-by-step breakdown of Health Canada's CTA filing process — covering CMC requirements, the 30-day review clock, and where contract research organizations add the most value.
Why NPN Applications Get Rejected in Canada — and How to Prevent It
Most NPN rejections in Canada are preventable. Learn the evidence requirements under SOR/2003-196 and the common submission mistakes that delay approvals.
Heavy Metal Testing for Natural Health Products in Canada: What the NHPR Requires and What Most Manufacturers Miss
How Health Canada's NHPR sets dose-based heavy metal limits for NHPs — and why most manufacturers get the ADI calculation wrong. Practical guidance for compliance.
Why NHP Product Licence Applications Get Rejected — And What Most Applicants Miss
Over 30% of NHP product licence applications trigger a Health Canada deficiency. Learn the most common submission mistakes and how to fix them before you file.
Drug Establishment Licence Renewal in Canada: Timeline, Fees, and Why Applications Get Rejected
Health Canada DEL renewal has firm deadlines, a cost-recovery fee structure, and GMP compliance conditions that can stall your application. Here's what to know.
Importing Health Products into Canada: Site Licensing, GMP Requirements, and Realistic Timelines
A practical guide for foreign manufacturers on Health Canada Site Licences, GMP requirements, and realistic timelines for importing health products into Canada.